Final outcomes of the SOFT and TEXT phase III trials in premenopausal hormonereceptor-positive early breast cancer Por [email protected] Final outcomes of the SOFT and TEXT phase III trials in premenopausal hormonereceptor-positive early breast cancer Read More »
A Prospective, Randomized Comparison ofClinical Outcomes with Different ProcessingTechniques in Autologous Fat Grafting Por [email protected] A Prospective, Randomized Comparison ofClinical Outcomes with Different ProcessingTechniques in Autologous Fat Grafting Read More »
Radiation therapy management in BRCA1/2 carriers diagnosed with earlybreast cancer: An international cohort study Por [email protected] Radiation therapy management in BRCA1/2 carriers diagnosed with earlybreast cancer: An international cohort study Read More »
Durvalumab in Combination With NeoadjuvantChemotherapy in Early Triple-Negative Breast Cancer:Long-Term Analysis From the GeparNuevo Trial Por [email protected] Durvalumab in Combination With NeoadjuvantChemotherapy in Early Triple-Negative Breast Cancer:Long-Term Analysis From the GeparNuevo Trial Read More »
Palbociclib plus letrozole versus weekly paclitaxel, both in combinationwith trastuzumab plus pertuzumab, as neoadjuvant treatment for patientswith HR-positive/HER2-positive early breast cancer: primary results fromthe randomized phase II TOUCH trial (IBCSG 55-17) Por [email protected] Palbociclib plus letrozole versus weekly paclitaxel, both in combinationwith trastuzumab plus pertuzumab, as neoadjuvant treatment for patientswith HR-positive/HER2-positive early breast cancer: primary results fromthe randomized phase II TOUCH trial (IBCSG 55-17) Read More »
Disparities in breast cancer incidence and survivalby age, race, and molecular subtype in US women Por [email protected] Disparities in breast cancer incidence and survivalby age, race, and molecular subtype in US women Read More »
Phase II Clinical Study of Adebrelimab and BevacizumabCombined With Cisplatin/Carboplatin in Patients WithTriple-Negative Breast Cancer With Brain Metastases(ABC Study) Por [email protected] Phase II Clinical Study of Adebrelimab and BevacizumabCombined With Cisplatin/Carboplatin in Patients WithTriple-Negative Breast Cancer With Brain Metastases(ABC Study) Read More »
Lymph Node Ratioasan Independent Prognostic Factor in Breast Cancer: A Retrospective Studyof 4060 Patients Undergoing Axillary Lymph Node Dissection Por [email protected] Lymph Node Ratioasan Independent Prognostic Factor in Breast Cancer: A Retrospective Studyof 4060 Patients Undergoing Axillary Lymph Node Dissection Read More »
The Pathologic Response Evaluation and Detection in Circulating Tumor-DNA Study: Ultrasensitive Circulating Tumor-DNA Assessment of Breast Cancer Minimal Residual Disease Por [email protected] The Pathologic Response Evaluation and Detection in Circulating Tumor-DNA Study: Ultrasensitive Circulating Tumor-DNA Assessment of Breast Cancer Minimal Residual Disease Read More »
Impact of Age on Use of Neoadjuvant Chemoimmunotherapyand Outcomes for Patients with Triple‑Negative Breast Cancer Por [email protected] Impact of Age on Use of Neoadjuvant Chemoimmunotherapyand Outcomes for Patients with Triple‑Negative Breast Cancer Read More »
Deep learning on histopathological images to predict breastcancer recurrence risk and chemotherapy benefit: a multicentre, model development and validation study Por [email protected] Deep learning on histopathological images to predict breastcancer recurrence risk and chemotherapy benefit: a multicentre, model development and validation study Read More »
Marking Techniques for Target Lymph Nodesin Node-Positive Breast Cancer Treated With NeoadjuvantTherapy in the AXSANA/EUBREAST-03/AGO-B-053 Study Por [email protected] Marking Techniques for Target Lymph Nodesin Node-Positive Breast Cancer Treated With NeoadjuvantTherapy in the AXSANA/EUBREAST-03/AGO-B-053 Study Read More »
